
FDA medical devices classification list
ITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER H - MEDICAL DEVICES
PART 866 |
- Scope.
- Effective dates of requirement for premarket approval.
- Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (the act).
- Antimicrobial susceptibility test disc.
- Antimicrobial susceptibility test powder.
- Fully automated short-term incubation cycle antimicrobial susceptibility system.
- System for detection of microorganisms and antimicrobial resistance using reporter expression.
- Culture medium for antimicrobial susceptibility tests.
- Staphylococcal typing bacteriophage.
- Anaerobic chamber.
- Coagulase plasma.
- Automated colony counter.
- Manual colony counter.
- Automated image assessment system for microbial colonies on solid culture media.
- Multipurpose culture medium.
- Differential culture medium.
- Enriched culture medium.
- Microbiological assay culture medium.
- Selective culture medium.
- Transport culture medium.
- Culture medium for pathogenic Neisseria spp.
- Oxidase screening test for gonorrhea.
- Automated medium dispensing and stacking device.
- Supplement for culture media.
- Quality control kit for culture media.
- Microtiter diluting and dispensing device.
- Microbiological incubator.
- Microbial growth monitor.
- Gas-generating device.
- Wood's fluorescent lamp.
- Microorganism differentiation and identification device.
- Streptococcus spp. nucleic acid-based assay.
- Automated zone reader.
- Microbiological specimen collection and transport device.
- Acinetobacter calcoaceticus serological reagents.
- Adenovirus serological reagents.
- Arizona spp. serological reagents.
- Aspergillus spp. serological reagents.
- In vitro diagnostic device for Bacillus spp. detection.
- Beta-glucan serological assays.
- Blastomyces dermatitidis serological reagents.
- Bordetella spp. serological reagents.
- Brucella spp. serological reagents.
- Campylobacter fetus serological reagents.
- Chlamydia serological reagents.
- Citrobacter spp. serological reagents.
- Clostridium difficile toxin gene amplification assay.
- Coccidioides immitis serological reagents.
- Corynebacterium spp. serological reagents.
- Coxsackievirus serological reagents.
- Cryptococcus neoformans serological reagents.
- Hepatitis C virus antibody tests.
- Nucleic acid-based hepatitis C virus ribonucleic acid tests.
- Cytomegalovirus serological reagents.
- Echinococcus spp. serological reagents.
- Echovirus serological reagents.
- Endotoxin assay.
- Device to detect and measure non-microbial analyte(s) in human clinical specimens to aid in assessment of patients with suspected sepsis.
- Entamoeba histolytica serological reagents.
- Enterovirus nucleic acid assay.
- Epstein-Barr virus serological reagents.
- Equine encephalomyelitis virus serological reagents.
- Erysipelothrix rhusiopathiae serological reagents.
- Escherichia coli serological reagents.
- Flavobacterium spp. serological reagents.
- Francisella tularensis serological reagents.
- Gonococcal antibody test (GAT).
- Haemophilus spp. serological reagents.
- Herpes simplex virus serological assays.
- Herpes virus nucleic acid-based cutaneous and mucocutaneous lesion panel.
- Hepatitis A virus (HAV) serological assays.
- Histoplasma capsulatum serological reagents.
- Influenza virus antigen detection test system.
- Influenza virus serological reagents.
- Reagents for detection of specific novel influenza A viruses.
- John Cunningham Virus serological reagents.
- Klebsiella spp. serological reagents.
- Leptospira spp. serological reagents.
- Listeria spp. serological reagents.
- Lymphocytic choriomeningitis virus serological reagents.
- Mass spectrometer system for clinical use for the identification of microorganisms.
- Multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures.
- Mycobacterium tuberculosis immunofluorescent reagents.
- Nucleic acid-based in vitro diagnostic devices for the detection of Mycobacterium tuberculosis complex in respiratory specimens.
- Nucleic acid-based in vitro diagnostic devices for the detection of Mycobacterium tuberculosis complex (MTB-complex) and the genetic mutations associated with MTB-complex antibiotic resistance in respiratory specimens.
- Mycoplasma spp. serological reagents.
- Mumps virus serological reagents.
- Neisseria spp. direct serological test reagents.
- Norovirus serological reagents.
- Parainfluenza virus serological reagents.
- Plasmodium species antigen detection assays.
- Poliovirus serological reagents.
- Proteus spp. (Weil-Felix) serological reagents.
- Pseudomonas spp. serological reagents.
- Rabiesvirus immunofluorescent reagents.
- Reovirus serological reagents.
- Respiratory syncytial virus serological reagents.
- Rhinovirus serological reagents.
- Rickettsia serological reagents.
- Rubella virus serological reagents.
- Rubeola (measles) virus serological reagents.
- Salmonella spp. serological reagents.
- Schistosoma spp. serological reagents.
- Serratia spp. serological reagents.
- Shigella spp. serological reagents.
- Sporothrix schenckii serological reagents.
- Staphylococcus aureus serological reagents.
- Streptococcus spp. exoenzyme reagents.
- Streptococcus spp. serological reagents.
- Toxoplasma gondii serological reagents.
- Treponema pallidum nontreponemal test reagents.
- Treponema pallidum treponemal test reagents.
- Trichinella spiralis serological reagents.
- Trichomonas vaginalis nucleic acid assay.
- Trypanosoma spp. serological reagents.
- Varicella-zoster virus serological reagents.
- Assayed quality control material for clinical microbiology assays.
- Vibrio cholerae serological reagents.
- West Nile virus serological reagents.
- Dengue virus serological reagents.
- Dengue virus nucleic acid amplification test reagents.
- In vitro human immunodeficiency virus (HIV) drug resistance genotype assay.
- Human immunodeficiency virus (HIV) drug resistance genotyping assay using next generation sequencing technology.
- Nucleic acid-based device for the amplification, detection, and identification of microbial pathogens directly from whole blood specimens.
- Device to detect and identify microbial pathogen nucleic acids in cerebrospinal fluid.
- Respiratory viral panel multiplex nucleic acid assay.
- Device to detect and identify microorganisms and associated resistance marker nucleic acids directly in respiratory specimens.
- Gastrointestinal microorganism multiplex nucleic acid-based assay.
- RNA Preanalytical Systems.
- Complement reagent.
- Immunoelectrophoresis equipment.
- Immunofluorometer equipment.
- Immunonephelometer equipment.
- Ouchterlony agar plate.
- Automated fluorescence in situ hybridization (FISH) enumeration systems.
- Automated indirect immunofluorescence microscope and software-assisted system.
- Radial immunodiffusion plate.
- Rocket immunoelectrophoresis equipment.
- Support gel.
- Albumin immunological test system.
- Prealbumin immunological test system.
- Human allotypic marker immunological test system.
- Alpha-1-antichymotrypsin immunological test system.
- Antimitochondrial antibody immunological test system.
- Antinuclear antibody immunological test system.
- Antiparietal antibody immunological test system.
- Antismooth muscle antibody immunological test system.
- Alpha-1-antitrypsin immunological test system.
- Bence-Jones proteins immunological test system.
- Beta-globulin immunological test system.
- Breast milk immunological test system.
- Fecal calprotectin immunological test system.
- Carbonic anhydrase B and C immunological test system.
- Ceruloplasmin immunological test system.
- Cohn fraction II immunological test system.
- Colostrum immunological test system.
- Complement components immunological test system.
- Complement C1 inhibitor (inactivator) immunological test system.
- Complement C3b inactivator immunological test system.
- C-reactive protein immunological test system.
- Properdin factor B immunological test system.
- Factor XIII, A, S, immunological test system.
- Ferritin immunological test system.
- Fibrinopeptide A immunological test system.
- Cohn fraction IV immunological test system.
- Cohn fraction V immunological test system.
- Free secretory component immunological test system.
- Alpha-globulin immunological test system.
- Alpha-1-glycoproteins immunological test system.
- Alpha-2-glycoproteins immunological test system.
- Beta-2-glycoprotein I immunological test system.
- Beta-2-glycoprotein III immunological test system.
- Haptoglobin immunological test system.
- Hemoglobin immunological test system.
- Hemopexin immunological test system.
- Hypersensitivity pneumonitis immunological test system.
- Immunoglobulins A, G, M, D, and E immunological test system.
- Immunoglobulin G (Fab fragment specific) immunological test system.
- Immunoglobulin G (Fc fragment specific) immunological test system.
- Immunoglobulin G (Fd fragment specific) immunological test system.
- Immunoglobulin (light chain specific) immunological test system.
- Lactic dehydrogenase immunological test system.
- Lactoferrin immunological test system.
- Alpha-1-lipoprotein immunological test system.
- Lipoprotein X immunological test system.
- Low-density lipoprotein immunological test system.
- Alpha-2-macroglobulin immunological test system.
- Beta-2-microglobulin immunological test system.
- Infectious mononucleosis immunological test system.
- Multiple autoantibodies immunological test system.
- Aquaporin-4 autoantibody immunological test system.
- Zinc transporter 8 autoantibody immunological test system.
- Myoglobin immunological test system.
- Whole human plasma or serum immunological test system.
- Plasminogen immunological test system.
- Prothrombin immunological test system.
- Radioallergosorbent (RAST) immunological test system.
- Tryptase test system.
- Retinol-binding protein immunological test system.
- Rheumatoid factor immunological test system.
- Anti-Saccharomyces cerevisiae (S. cerevisiae) antibody (ASCA) test systems.
- Seminal fluid (sperm) immunological test system.
- Systemic lupus erythematosus immunological test system.
- Brain trauma assessment test.
- Total spinal fluid immunological test system.
- Thyroid autoantibody immunological test system.
- Transferrin immunological test system.
- Inter-alpha trypsin inhibitor immunological test system.
- Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation detection system.
- Quality control material for cystic fibrosis nucleic acid assays.
- Newborn screening test for severe combined immunodeficiency disorder (SCID).
- Autosomal recessive carrier screening gene mutation detection system.
- Genetic health risk assessment system.
- Tumor-associated antigen immunological test system.
- Immunomagnetic circulating cancer cell selection and enumeration system.
- AFP-L3% immunological test system.
- Gene expression profiling test system for breast cancer prognosis.
- Ovarian adnexal mass assessment score test system.
- BCR-ABL quantitation test.
- Next generation sequencing based tumor profiling test.
Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 360l, 371.
Source: 47 FR 50823, Nov. 9, 1982, unless otherwise noted.